Skip to main content
OpenTrials
Completed

NCT Number: NCT00771459

Local Infiltration Analgesia in Major Spine Surgery With Ropivacaine Versus Placebo

The purpose of this study is to examine whether local infiltration analgesia (LIA) with Ropivacaine and adrenaline is effective in the treatment of postoperative pain after major spine surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hvidovre University Hospital

Copenhagen, Hvidovre, 2650, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients eligible for major spine surgery
  • must speak and understand Danish
  • must be able to give oral and written consent

Exclusion criteria

  • alcohol or medicine abuse
  • treatment with opioids > 100 mg daily
  • allergy to local anesthetics
  • severe obesity

Treatment and study plan

Ropivacaine 0.5 %

Drug

Local infiltration analgesia

Isotonic NaCl

Drug

Local infiltration analgesia

Primary outcomes

  1. Postoperative Pain

    Time frame: 0-48 h postoperatively

Secondary outcomes

  1. Analgesia consumption

    Time frame: 0-48 h postoperatively

Sponsors and collaborators

Lead sponsor

Hvidovre University Hospital

Other

Registry information

Official study title

Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Placebo Ved Rygkirurgi for Spinalstenose: et Prospektivt Randomiseret, Dobbeltblindet, Placebo-kontrolleret Studie

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Oct 13, 2008
Registry last updated
Jun 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.